Эректильная дисфункция - разные решения одной проблемы, или Размышления на заданную тему
https://doi.org/10.21518/2079-701X-2014-19-64-71
Аннотация
Эректильная дисфункция (ЭД) и преждевременная эякуляция (ПЭ) - это две основные жалобы, встречающиеся в мужской сексуальной медицине [1, 2, 14]. Эректильная дисфункция - проблема весьма деликатная, и далеко не каждый мужчина решится поведать о ней врачу. Подобная неприятность может произойти в любом возрасте, и плохая эрекция нередко становится настоящей трагедией для представителей сильного пола. Дисбаланс в семейной жизни может стать причиной серьезного снижения качества жизни, появления проблем на работе и даже развития тяжелой депрессии.
Об авторах
П. И. Раснер
Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава России
Россия
Россия
Д. Ю. Пушкарь
Московский государственный медико-стоматологический университет им. А.И. Евдокимова Минздрава России
Россия
Россия
Список литературы
1. Lindau ST, Schumm LP, Laumann EO et al. N Engl J Med, 2007, Aug, 23, 357 (8): 762-74.
2. Rosenberg MT, Sadovsky R. Identification and diagnosis of premature ejaculation. Int J Clin Pract, 2007, Jun, 61 (6): 903-8.
3. Schultheiss D, Gabouev AI, Jonas U. Nikolaj A. Bogoraz (1874-1952): pioneer of phalloplasty and penile implant surgery. J Sex Med, 2005, Jan, 2 (1): 139-46.
4. Leungwattanakij S, Flynn V Jr, Hellstrom WJ. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am, 2001, May, 28 (2): 343-54.
5. Wespes E, Schulman C. Venous impotence: pathophysiology, diagnosis and treatment. J Urol, 1993, May, 149 (5 Pt 2): 1238-45.
6. Rao DS, Donatucci CF. Vasculogenic impotence. Arterial and venous surgery. Urol Clin North Am, 2001, May, 28 (2): 309-19.
7. Moncada I, Jara J, Subira D, et al. Efficacy of sildenafil citrate at 12 hours after dosing: re-exploring the therapeutic window. Eur Urol, 2004, Sep, 46 (3): 357-60, discussion 360-1.
8. Rosen RC. Psychogenic erectile dysfunction. Classification and management. Urol Clin North Am, 2001, May, 28 (2): 269-78.
9. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int JImpot Res, 2000, Dec, 12 (6): 305-11.
10. Johannes CB, Araujo AB, Feldman HA, et al. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J Urol, 2000, Feb,163 (2): 460-3.
11. Schouten BW, Bosch JL, Bernsen RM, et al. Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study. Int J Impot Res, 2005, Jan-Feb, 17 (1): 58-62.
12. Lee JC, Benard F, Carrier S, et al. Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population? BJUInt, 2011, Mar, 107 (6): 956-60.
13. Иремашвили В.В. Значение исследования эндотелиальной функции у больных эректильной дисфункцией. Дис.. канд. мед. наук. М., 2006.
14. Hatzimouratidis K. (chair), Eardley I., Giuliano F., Hatzichristou D., Moncada I., Salonia A., Vardi Y., Wespes E. Guidelines on Male Sexual Dysfunction: Erectile dysfunction andpremature ejaculation. EAU, 2014.
15. Langtry HD, Markham A. Sildenafil: a review of its use in erectile dysfunction. Drugs, 1999, Jun, 57 (6): 967-89.
16. Taylor J. et al. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors. BJU Int., 2009, 103: 1392-1395.
17. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N EngIJ Med, 1998, 338: 1397-1404.
18. Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res, 2001, 13 (4): 192-99.
19. Padma-Nathan H, Rosen R, Shabsigh R, Saikali K, Watkins V, Pullman W. Tadalafil (IC351) provides prompt response and extended period of responsiveness for the treatment of men with erectile dysfunction (ED). Int J Impot Res, 2001, 13 (Suppl. 4): S33.
20. Локшин К.Л. Сравнительная характеристика силденафила и других ингибиторов фосфодиэстеразы 5 типа в лечении больных эректильной дисфункцией (обзор литературы). РМЖ, 2014, 18: 936-938.
21. Morelli G. et al. Final report. MDS PS PROJECT, 2007, AM3741.
22. Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: Qualitative study. BMJ, 2004, 328: 1037-40.
23. Conaglen HM, Conaglen JV. The impact of erectile dysfunction on female partners: A qualitative investigation. Sex Relat Ther (in press).
24. Edwards D, Hackett GI, Collins O, Curram J. Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): A randomized double-blind, placebocontrolled trial in PDE5 inhibitor-naive men with ED and their partners. J Sex Med, 2006, 3: 1028-36.
25. Rosen R, Janssen E, Wiegel M, Bancroft J, Althof S, Wincze J, Segraves RT, Barlow D. Psychological and interpersonal correlates in men with erectile dysfunction and their partners: A pilot study of treatment outcome with sildenafil. J Sex Marital Ther, 2006, 32: 215-34.
26. Lee J, Pommerville P, Brock GB, Gagnon R, Mehta P, Krisdaphongs M, Chan M, Chan J, Dickson R. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: Results from the Canadian "Treatment of Erectile Dysfunction" observational study. BJU Int, 2006, 98: 623-9.
27. Mazo EB, Gamidov SI, Iremashvili VV. Does the clinical efficacy of vardenafil correlate with its effect on the endothelial function of cavernous arteries? A pilot study BJU Int., 2006, 98: 1054-1058.
28. McMahon CG. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to ondemand tadalafil. J Sex Med, 2004, 1: 292-300.
29. Hatzimouratidis K, Moysidis K, Bekos A, et al. Treatment strategy for "non-responders" to tadalafil and vardenafil: a real-life study. Eur Urol, 2006, 50: 126-133.
30. Bella AJ, Deyoung LX, Al-Numi M, Brock GB. Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications. Eur Urol, 2007, 52: 990-1005.
31. Раснер П.И., Пушкарь Д.Ю. Левитра, растворяющаяся в полости рта, - новый шаг в лечении пациентов с эректильной дисфункцией. Урология, 2013, 4: 93-98.
32. Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP A review of outcomes of an intracavernosal injection therapy programme. BJU Int, 2012, Dec, 110 (11): 1787-91.
33. Leungwattanakij S, Flynn V Jr, Hellstrom WJ. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am, 2001, May, 28 (2): 343-54.
34. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol, 1996, Mar, 155 (3): 802-15.
35. Lakin MM, Montague DK, VanderBrug Medendorp S, et al. Intracavernous injection therapy: analysis of results and complications. J Urol, 1990, Jun, 143 (6): 1138-41.
36. Sundaram CP, Thomas W, Pryor LE, et al. Long-term follow-up of patients receiving injection therapy for erectile dysfunction. Urology, 1997, Jun, 49 (6): 932-5.
37. Levine LA, Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am, 2001, May, 28 (2): 335-41, ix-x.
38. Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J Urol, 1997, 15 (1): 78-82.
39. Montague DK. Penile prosthesis implantation in the era of medical treatment for erectile dysfunction. Urol Clin North Am, 2011, May, 38 (2): 217-2.
40. Mulhall JP, Ahmed A, Branch J, et al. Serial assessment of efficacy and satisfaction profiles following penile prosthesis surgery./ Urol, 2003, Apr, 169 (4): 1429-33.
41. Carson CC, Mulcahy JJ, Govier FE. Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. aMs 700CX Study Group. J Urol, 2000, Aug, 164 (2): 376-80.
Рецензия
Для цитирования:
Раснер П.И., Пушкарь Д.Ю. Эректильная дисфункция - разные решения одной проблемы, или Размышления на заданную тему. Медицинский Совет. 2014;(19):64-71. https://doi.org/10.21518/2079-701X-2014-19-64-71
For citation:
Rasner P., Pushkar D. Erectile dysfunction: different solutions for the same problem, or reflections on the subject. Meditsinskiy sovet = Medical Council. 2014;(19):64-71. (In Russ.) https://doi.org/10.21518/2079-701X-2014-19-64-71
Просмотров: 285
Послать статью по эл. почте 